| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ENOV | Common stock, par value $0.001 | Award | $0 | +13,793 | +11% | $0.000000 | 140,906 | 17 Feb 2025 | Direct | F1 |
| transaction | ENOV | Common stock, par value $0.001 | Tax liability | $289,630 | -6,599 | -4.7% | $43.89 | 134,307 | 17 Feb 2025 | Direct | F2 |
| holding | ENOV | Common stock, par value $0.001 | 932 | 17 Feb 2025 | By 401k plan | ||||||
| holding | ENOV | Common stock, par value $0.001 | 333 | 17 Feb 2025 | By trust for daughter | ||||||
| holding | ENOV | Common stock, par value $0.001 | 333 | 17 Feb 2025 | By trust for daughter | ||||||
| holding | ENOV | Common stock, par value $0.001 | 333 | 17 Feb 2025 | By trust for son |
| Id | Content |
|---|---|
| F1 | Reflects the certification of the performance criteria for performance-based restricted stock units ("PRSUs") previously awarded in 2022. For more details on the PRSUs, please refer to the "Outstanding Equity Awards at 2023 Fiscal Year-End" table on page 44 of Enovis Corporation's proxy statement as filed with the Securities and Exchange Commission on April 5, 2024. |
| F2 | Represents shares that have been withheld by the Company to satisfy tax withholding and remittance obligations in connection with the net settlement of PRSUs and time-based restricted stock units and does not represent a sale by the reporting person. |